Pub. Date : 2019 Apr
PMID : 30937121
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Differing Effect of the Sodium-Glucose Cotransporter 2 Inhibitor Ipragliflozin on the Decrease of Fat Mass vs. | ipragliflozin | solute carrier family 5 member 2 | Homo sapiens |
| 2 | Background: We previously reported changes of body composition determined by dual-energy X-ray absorptiometry after treatment with ipragliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor. | ipragliflozin | solute carrier family 5 member 2 | Homo sapiens |
| 3 | Background: We previously reported changes of body composition determined by dual-energy X-ray absorptiometry after treatment with ipragliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor. | ipragliflozin | solute carrier family 5 member 2 | Homo sapiens |